Keyword :   chemotherapy

2340_01Circulating tumor cells in breast cancer: functional heterogeneity, pathogenetic and clinical aspects
Authors :Cherdyntseva N.V. Litviakov N.V. Denisov E.V. Gervas P.A.... Vol. 39, No. 1 / Views: 770
Treatment of large osteosarcoma in children: new approachTreatment of large osteosarcoma in children: new approach
Authors :Kobys V.L. Konovalenko V.F. Repinа N.V. Golovko T.S.... Date: 2013-06-25 / Views: 670
SERUM SELENIUM CONCENTRATION AND ANTIOXIDANT ACTIVITY IN CERVICAL CANCER PATIENTS BEFORE AND AFTER TREATMENTSerum selenium concentration and antioxidant activity in cervical cancer patients before and after treatment
Authors :Subramanyam D. Subbaiah K.C.V. Rajendra W. Lokanatha V. Date: 2013-06-25 / Views: 827
Enterosorption as a method to decrease the systemic toxicity of cisplatin
Authors :Yurchenko O.V. Sakhno L.A. Korotich V.G. Maslenniy V.N.... Vol. 35, No. 1 / Views: 515
Antitumor and adjuvant effects of phagelysates of E.coli in mice with Ehrlich carcinoma
Authors :Gambashidze K. Khorava P. Azaladze T. Kalandarishvili K.... Vol. 34, No. 2 / Views: 384
e1METFORMIN PLUS PIAF COMBINATION CHEMOTHERAPY FOR HEPATOCELLULAR CARCINOMA
Authors :Petrushev B. Tomuleasa C. Soritau O. Aldea M.... Date: 2012-03-21 / Views: 1362
CADRALAZINE: A LESS TOXIC BUT EQUALLY EFFECTIVE ANALOGUE OF HYDRALAZINE IN VIVO
Authors :Horsman M.R. Chaplin D.J. Overgaard J. 1 / Views: 92
HYPERCOAGULANT STATES IN MALIGNANT LYMPHOMA
Authors :Wada H. Sase T. Yamaguchi M. Vol. 27, No. 3 / Views: 50
SERUM LEVELS OF IGF-I AND IGF-II IN PATIENTS WITH LUNG CANCER DURING CHEMOTHERAPY
Authors :Izycki T. Chyczewska E. Naumnik W. Talalaj J.... Vol. 26, No. 4 / Views: 56
Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia
Authors :Horacek J.M. Tichy M. Jebavy L. Pudil R.... Vol. 30, No. 2 / Views: 107
MOLECULAR AND CLINICAL CONDITIONS ASSOCIATED WITH VENOUS THROMBOEMBOLISM IN ONCOLOGICAL PATIENTS
Authors :Micco P. Di Amitrano M. Niglio A. Fontanella A. Vol. 28, No. 3 / Views: 24
SERUM LEVELS OF SFAS AND SFASL DURING CHEMOTHERAPY OF LUNG CANCER
Authors :Naumnik iW. Izycki T. Ossolinska M. Chyczewskabr E. Vol. 29, No. 2 / Views: 67